Signatur Biosciences

Private Company

Making precision diagnostics accessible.

Biotechnology Research
London, UK
2-10 employees
Founded 2022

About Signatur Biosciences

Making precision diagnostics accessible. | Signatur Biosciences makes precision diagnostics more accessible, starting by bringing breast cancer testing within reach for women around the world.

Traditional tests used to guide therapy are slow and expensive due to their reliance on complex, centralized facilities. Our tests are designed to seamlessly integrate with standard instruments and workflows already in place in every clinical lab.

Funding

Total Funding

$500.0K

No. of Funding Rounds

1

Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.

Sign up to Ethos